ClinicalTrials.Veeva

Menu

Universal Biospecimen Collection Protocol for Extra Material From Clinical Pulmonary Procedures

M.D. Anderson Cancer Center logo

M.D. Anderson Cancer Center

Status

Enrolling

Conditions

Pulmonary

Study type

Observational

Funder types

Other

Identifiers

NCT07218939
2025-1394
NCI-2025-07702 (Other Identifier)

Details and patient eligibility

About

The goal of this study is to develop a biospecimen collection protocol for unused biospecimens from pulmonary procedures in order to facilitate research across many different areas of pulmonary medicine and mitigate the pulmonary morbidity experienced by patients with cancer.

Full description

Primary objectives:

To assemble a tissue/blood bank biorepository for laboratory translational research by collecting extra samples of bronchoalveolar lavage, pleural fluid, blood or other residual tissue obtained during normally scheduled clinical procedures for the evaluation of pulmonary toxicity

To collect basic data on patient data and suspected pulmonary toxicity to cross-reference eligible biospecimens

Enrollment

12,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

All patients over the age of 18, who are seen in the Cardiopulmonary Center and are undergoing pulmonary procedures

Exclusion criteria

Pregnant women and prisoners

Trial contacts and locations

1

Loading...

Central trial contact

Ajay Sheshadri, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems